항생제 내성과 슈퍼박테리아

항생제 내성은 세균이 항생제에 적응해 약이 안 듣게 되는 현상. '슈퍼박테리아'가 바로 이것. WHO가 21세기 최대 보건 위협으로 지목.

왜 생기나

대표 슈퍼박테리아

한국 상황

새 항생제 왜 안 만드나

대안

관련 항목

포스트 항생제 시대

병원 감염

음식으로도 전파

내가 할 수 있는 것

관련 항목

항생제 내성 요약

항생제는 세균을 죽이는 약이에요. 의사 선생님이 처방해주는 중요한 약인데, 잘못 사용하면 약이 듣지 않게 될 수 있어요.

항생제를 올바르게 써야 해요

슈퍼박테리아가 뭔가요?

더 알아보기

손씻기가 왜 중요한가요?

과학자들이 지구를 지키고 있어요

더 알아보기

건강을 지키는 방법

Antibiotic Resistance

Antibiotic resistance occurs when bacteria evolve to withstand antibiotics, rendering treatments ineffective. Particularly concerning are multidrug-resistant bacteria, often dubbed "superbacteria," which are resistant to most existing antibiotics and can lead to fatal outcomes in infections. The World Health Organization (WHO) categorizes antibiotic resistance as one of the most severe health threats facing humanity in the 21st century.

History and Misuse of Antibiotics

The discovery of penicillin by Alexander Fleming in 1928 marked a pivotal moment, providing humanity with potent weapons against bacterial infections. However, decades of misuse and overuse of antibiotics have enabled bacteria to develop resistance. Practices such as widespread antibiotic administration to livestock for growth promotion and disease prevention, coupled with easy access to antibiotics without prescriptions, significantly contribute to the spread of resistant strains.

Key Superbacteria

• MRSA (Methicillin-Resistant Staphylococcus Aureus): A formidable pathogen causing infections ranging from skin conditions to sepsis, often resistant to most antibiotics. Globally, it is estimated that MRSA infections claimed around 1 million lives in 2023.
• CRE (Carbapenem-Resistant Enterobacteriaceae): Known as "last-resistance antibiotics," CRE resist carbapenem antibiotics, leading to mortality rates exceeding 50% in some cases.
• NDM-1 Producing Bacteria: First identified in India, these bacteria produce enzymes that confer resistance to multiple antibiotics, spreading globally.

Korean Context

South Korea ranks among the top OECD countries in antibiotic usage. Until early 2020s, antibiotics were frequently prescribed for viral illnesses like colds and flu. Efforts by the Health Insurance Review & Assessment Service (HIRA) to promote appropriate antibiotic use have led to a slight decrease in usage since the 2010s, though self-medication remains a concern.

Challenges in Developing New Antibiotics

The development of new antibiotics struggles to keep pace with bacterial resistance evolution. Developing a new antibiotic requires approximately 10-15 years and billions of dollars, yet bacteria can acquire resistance within years. Low return on investment deters pharmaceutical companies, exacerbating the issue of antibiotic development avoidance.

Alternatives and Future Directions

• Phage Therapy: Utilizing bacteriophages—viruses that infect bacteria—to combat resistant strains, with active clinical research.
• Peptide Antibiotics: These directly disrupt bacterial cell membranes, making resistance development more challenging.
• AI in Drug Discovery: Leveraging artificial intelligence to rapidly identify novel antibiotic candidates.

Related Topics

• Penicillin
• Antibiotics
• MRSA
• WHO
• Infectious Diseases
• Public Health
• Drug Resistance
• Biopharmaceuticals

Warning of the 'Post-Antibiotic Era'

Organizations like WHO and global health bodies warn of the impending "Post-Antibiotic Era." Projections suggest that if current trends continue, antibiotic resistance could claim up to 10 million lives annually by 2050—surpassing cancer fatalities each year. The 2007 UK case of MRSA-related death underscores the urgent need for global action, highlighting that safe surgical procedures may no longer be feasible.

Hospital Infection Control

Superbacteria pose a significant threat particularly in hospital settings, targeting immunocompromised patients such as post-operative individuals, neonates, and the elderly. Enhanced hand hygiene protocols and isolation wards are crucial preventive measures, evident in major Korean hospitals where MRSA and VRE (Vancomycin-Resistant Enterococci) infections persist, prompting stricter infection control measures.

Link to Food Safety

Another critical pathway for antibiotic resistance transmission is through food. Antibiotic residues in meat from livestock treated extensively can transfer resistance to humans. Consequently, the EU banned the use of antibiotics for growth promotion in livestock in 2006, while South Korea prohibited such use in 2011, though therapeutic use remains permitted.

Related Topics

• Antibiotics
• MRSA
• WHO
• Infectious Diseases
• Phage Therapy
• Public Health
• Hospital Infections
• Food Safety

Antibiotic resistance stands as a paramount public health challenge of the 21st century, necessitating both individual responsible antibiotic use and concerted international efforts to address this escalating crisis.

English version not yet available.

English version not yet available.